280 related articles for article (PubMed ID: 18350399)
21. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
22. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.
Tohda Y; Fujimura M; Taniguchi H; Takagi K; Igarashi T; Yasuhara H; Takahashi K; Nakajima S
Clin Exp Allergy; 2002 Aug; 32(8):1180-6. PubMed ID: 12190656
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
24. [The effect of montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction].
Sun TY; Guo YF; Xu XM; Zhang HS; Hou J; Ke HX; Li YM; Fang BM; Ming SH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):83-7. PubMed ID: 15854387
[TBL] [Abstract][Full Text] [Related]
25. Montelukast in guidelines and beyond.
Bousquet J; Demoly P; Humbert M
Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
[TBL] [Abstract][Full Text] [Related]
26. Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough.
Kita T; Fujimura M; Ogawa H; Nakatsumi Y; Nomura S; Ishiura Y; Myou S; Nakao S
Allergol Int; 2010 Jun; 59(2):185-92. PubMed ID: 20299826
[TBL] [Abstract][Full Text] [Related]
27. [Montelukast in treatment mild chronic asthma].
Lis G; Cichocka-Jarosz E; Głodzik I; Szczerbiński T; Białoruska B
Pneumonol Alergol Pol; 2001; 69(5-6):257-64. PubMed ID: 11732287
[TBL] [Abstract][Full Text] [Related]
28. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.
Kawai S; Baba K; Matsubara A; Shiono H; Okada T; Yamaguchi E
J Asthma; 2008 Apr; 45(3):243-50. PubMed ID: 18415834
[TBL] [Abstract][Full Text] [Related]
30. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
31. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
[TBL] [Abstract][Full Text] [Related]
32. Effects of supportive treatment such as antioxidant or leukotriene receptor antagonist drugs on inflammatory and respiratory parameters in asthma patients.
Tug T; Godekmerdan A; Sari N; Karatas F; Erdem ES
Clin Pharmacol Ther; 2007 Mar; 81(3):371-6. PubMed ID: 17339866
[TBL] [Abstract][Full Text] [Related]
33. Premenstrual asthma: prevalence, cycle-to-cycle variability and relationship to oral contraceptive use and menstrual symptoms.
Murphy VE; Gibson PG
J Asthma; 2008 Oct; 45(8):696-704. PubMed ID: 18951263
[TBL] [Abstract][Full Text] [Related]
34. Montelukast: new preparation. No current use in asthma.
Prescrire Int; 1999 Oct; 8(43):131-4. PubMed ID: 11503835
[TBL] [Abstract][Full Text] [Related]
35. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R
Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233
[TBL] [Abstract][Full Text] [Related]
36. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
[TBL] [Abstract][Full Text] [Related]
37. Discrepant clinical responses and blood chemokine profiles between two non-steroidal anti-inflammatory medications for children with mild persistent asthma.
Hung CH; Li CY; Lai YS; Hsu PC; Hua YM; Yang KD
Pediatr Allergy Immunol; 2005 Jun; 16(4):306-9. PubMed ID: 15943593
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of montelukast as monotherapy in children with mild persistent asthma.
Ghosh G; Manglik AK; Roy S
Indian Pediatr; 2006 Sep; 43(9):780-5. PubMed ID: 17033116
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of ASS-Associated Polyposis (ASSAP) with a cysteinyl leukotriene receptor antagonist - a prospective drug study on its antiinflammatory effects].
Grundmann T; Töpfner M
Laryngorhinootologie; 2001 Oct; 80(10):576-82. PubMed ID: 11602930
[TBL] [Abstract][Full Text] [Related]
40. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.
Zhang J; Yu C; Noonan G; Reiss TF
Clin Ther; 2002 Apr; 24(4):574-82. PubMed ID: 12017402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
